Many people regain weight after stopping, which is why ongoing treatment is often recommended
At Novo Nordisk, our goal is to provide innovative therapies that support healthier lives for people living with obesity, and we look forward to launching Wegovy HD to help even more people reach their weight and health goals. Novo Nordisk expects to launch Wegovy HD in a single-dose pen in the US in April 2026
Kidney outcomes included a composite of 50% reduction in estimated glomerular filtration rate, kidney failure or death caused by kidney failure, and annualized rate of decline in estimated glomerular filtration rate (estimated glomerular filtration rate slope)
This can be done orally, topically, intravenously, intranasally, or in nebulised form
There is no firm evidence to support L-carnitine use on rest days